Finding a way to augment the expression of this gene in adult cells may have profound implications for promoting health and possibly reversing some of the detrimental effects with ageing," said Gary K Owens, from the University of Virginia (UVA) School of Medicine.
The gene, Oct4, plays a key role in the development of all living organisms, but scientists have, until now, thought it was permanently inactivated after embryonic development.
The researchers found that Oct4 controls the movement of smooth muscle cells into protective fibrous "caps" inside the plaques - caps that make the plaques less likely to rupture.
They also have provided evidence that the gene promotes many changes in gene expression that are beneficial in stabilising the plaques.
Also Read
Studies suggest that it may be possible to develop drugs or other therapeutic agents that target the Oct4 pathway as a means to reduce the incidence of heart attacks or stroke.
Instead, the plaques grew larger, less stable and more dangerous, stuffed with lipids, dead cells and other damaging components.
Apart from cardiovascular protection, the gene could also prove critical to the field of regenerative medicine, which investigates the growth and replacement of tissues and organs, researchers said.
Researchers believe that Oct4 and its family of target genes are activated in other somatic cells - the non-reproductive cells in the body - and play a key role in the cells' ability to repair damage and heal wounds.
The researchers suspect that at least some of the detrimental effects of ageing, including the increased possibility of a plaque rupture, stem from a decrease in the body's ability to reactivate Oct4.
"Finding a way to reactivate this pathway may have profound implications for health and ageing," Owens said.
"Who knows, this may end up being the 'fountain-of-youth gene,' a way to revitalise old and worn-out cells," he said.